[1] III. NKF-K/DOQI, “Clinical, Practice Guidelines for Vascular Access: Update 2000,” American Journal of Kidney Diseases, Vol. 37, No. 1, 2001, pp. S137-S181. http://dx.doi.org/10.1016/S0272-6386(01) 70007-8
[2] J. Ethier, et al., “Vascular Access Use and Outcomes: An International Perspective from the Dialysis Outcomes and Practice Patterns Study,” Nephrology Dialysis Transplantation, Vol. 23, No. 10, 2008, pp. 3219-3126. http://dx.doi.org/10.1093/ndt/gfn261
[3] J. A. Akoh, “Vascular Access Infections: Epidemiology, Diagnosis, and Management,” Current Infectious Disease Reports, Vol. 13, No. 4, 2011, pp. 324-332. http://dx.doi.org/10.1007/s11908-011-0192-x
[4] P. Ponce, et al., “A Prospective Study on Incidence of Bacterial Infections in Portuguese Dialysis Units,” Nephron Clinical Practice, Vol. 107, No. 4, 2007, pp. 133138. http://dx.doi.org/10.1159/ 000110033
[5] K. B. Stevenson, et al., “Epidemiology of Hemodialysis Vascular Access Infections from Longitudinal Infection Surveillance Data: Predicting the Impact of NKF-DOQI Clinical Practice Guidelines for Vascular Access,” American Journal of Kidney Diseases, Vol. 39, No. 3, 2002, pp. 549-555.
http://dx.doi.org/10.1053/ajkd.2002.31405
[6] L. A. Colville and A. H. Lee, “Retrospective Analysis of Catheter-Related Infections in a Hemodialysis Unit,” Infection Control and Hospital Epidemiology, Vol. 27, No. 9, 2006, pp. 969-973.
http://dx.doi.org/10.1086/507821
[7] P. Bachleda, et al., “Infectious Complications of Arteriovenous ePTFE Grafts for Hemodialysis,” Biomedical Papers, Vol. 154, No. 1, 2010, pp. 13-19. http://dx.doi.org/10.5507/bp.2010.005
[8] W. P. Schutte, et al., “Surgical Treatment of Infected Prosthetic Dialysis Arteriovenous Grafts: Total versus Partial Graft Excision,” The American Journal of Surgery, Vol. 193, No. 3, 2007, pp. 385-388. http://dx.doi.org/10.1016/j.amjsurg.2006.09.028
[9] I. Saeed Abdulrahman, et al., “A Prospective Study of Hemodialysis Access-Related Bacterial Infections,” Journal of Infection and Chemotherapy, Vol. 8, No. 3, 2002, pp. 242-246.
http://dx.doi.org/10.1007/s10156-002-0184-8
[10] J. L. Bruggink, et al., “Accuracy of FDG-PET-CT in the Diagnostic Work-Up of Vascular Prosthetic Graft Infection,” European Journal of Vascular and Endovascular Surgery, Vol. 40, No. 3, 2010, pp. 348-354. http://dx.doi.org/10.1016/j.ejvs.2010.05.016
[11] R. Kumar, et al., “Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography,” Clinical Microbiology Reviews, Vol. 21, No. 1, 2008, pp. 209-224. http://dx.doi.org/10.1128/CMR.00025-07
[12] M. G. van der Vaart, et al., “Application of PET/SPECT Imaging in Vascular Disease,” European Journal of Vascular and Endovascular Surgery, Vol. 35, No. 5, 2008, pp. 507-513.
http://dx.doi.org/10.1016/j.ejvs.2007.11.016
[13] P. Fiorani, et al., “Detection of Aortic Graft Infection with leukocytes Labeled with Technetium 99m-Hexametazime,” Journal of Vascular Surgery, Vol. 17, No. 1, 1993, pp. 87-95.
http://dx.doi.org/10.1016/0741-5214(93)90012-B
[14] S. Basu, et al., “Positron Emission Tomography as a Diagnostic Tool in Infection: Present Role and Future Possibilities,” Seminars in Nuclear Medicine, Vol. 39, No. 1, 2009, pp. 36-51.
http://dx.doi.org/10.1053/j.semnuclmed.2008.08.004
[15] K. Fukuchi, et al., “Detection of Aortic Graft Infection by Fluorodeoxyglucose Positron Emission Tomography: Comparison with Computed Tomographic Findings,” Journal of Vascular Surgery, Vol. 42, No. 5, 2005, pp. 919-925. http://dx.doi.org/10.1016/j.jvs.2005.07.038
[16] Z. Keidar, et al., “Prosthetic Vascular Graft Infection: The Role of 18F-FDG PET/CT,” Journal of Nuclear Medicine, Vol. 48, No. 8, 2007, pp. 1230-1236. http://dx.doi.org/10.2967/jnumed.107.040253